New obligations for EU imports to register their goods potentially subject to anti-dumping or anti-subsidy investigation measures
The European Commission recently decided that the customs authorities will now register all imports of products under anti-dumping or anti-subsidy investigations, including ongoing investigations where provisional determinations have not yet been made.
Regulations explaining how it will work in practice will be published by the European Commission in due course, but it can already be seen that the new import registration requirements carry several important implications for businesses:
- Automatic registration: Unlike the previous system where imports were registered only upon a justified request from the EU industry, the new policy mandates automatic registration of all imports under investigation. This change aims to streamline the process and reduce the administrative burden on industries, ensuring a more efficient and transparent system.
- Enhanced data collection: The registration process will enable the European Commission to gather detailed information about the source and quantities of imports, as well as broader market trends. This data is crucial for making informed decisions and implementing effective trade defence measures.
- Potential for retroactive duties: One of the most significant aspects of the new measure is the possibility of retroactively collecting anti-dumping and countervailing duties if the legal conditions are met. This means that businesses could face additional financial liabilities for past imports if investigations conclude that unfair trade practices were involved.
For businesses importing goods into the European Union, it is now more important than ever to ensure compliance with a range of regulations and to stay informed about ongoing investigations. The companies now also need to monitor ongoing proceedings and analyse whether the European Commission has recently initiated proceedings for similar goods. These proceedings could result in the imposition of additional duties with retroactive effect, making it crucial to stay informed and prepared.
In this regard, the importance of accurate tariff classification, origin determination and customs value of imported goods cannot be overstated. These factors will ultimately influence whether additional anti-dumping duties can be charged after the importation of goods.
The European Commission’s new measures on import registration represent a significant shift in trade defence strategy. For businesses importing to the EU, staying informed and compliant is crucial to avoid potential financial liabilities and to maintain a competitive edge in the market.
Pharma VAT recovery for rebates granted under KVV Art. 71a: a smart business move for you
Pharmaceutical companies selling drugs listed on the Speciality List (SL) in Switzerland have the opportunity to gain a valuable VAT benefit that could significantly enhance their financial standing. The reason for this opportunity is a recent shift in the approach of health and/or disability insurers regarding the rebates required under Swiss law (KVV Article 71a).
Previously, pharmaceutical companies had to grant rebates for Specialty List (SL) medicines under KVV Art. 71a if those drugs had been used in special cases; the price had to be below the price listed on the SL with no further stipulation in the law.
Non-SL drugs (which typically are not reimbursed by the health insurance) are reimbursed in special cases under KVV Art. 71b; the prices in those cases were subject to negotiation between the health insurance and the pharmaceutical company. Rebates in those cases were not obligatory, but often agreed upon in the negotiations.
The partial revision of the KVV which went into force on 1 January 2024 now requires pharmaceutical companies to grant a set percentage of rebate on drugs reimbursed in special cases, and regardless of whether those drugs are listed in the SL or not, the same rebates apply for both SL and non-SL drugs.
Until recently, these rebates were usually issued with VAT on the credit notes, but recently, many insurers have requested the credit notes to be issued without VAT, to avoid any VAT risk on their side.
This change implies that pharmaceutical companies may have inadvertently had VAT on these rebates in the past that can be claimed back. The good news is that such overpaid VAT amounts can be reclaimed from the Swiss VAT authorities, provided that a VAT ruling confirming this option is in place. We’ve been instrumental in assisting numerous pharmaceutical clients in securing these rulings, enabling them to recoup substantial VAT sums spanning the past five years.
A comprehensive exploration of the KVV Art. 71a to c revision from a tax perspective can be found in our recent blog post.
Our Swiss pharma regulatory and indirect tax experts are looking forward to discussing VAT refund opportunities together with you.
E-Invoicing
France
A new decree has been published on plans for the delayed rollout of French mandatory e-invoicing and B2C e-reporting.
The rollout plan is now as follows:
- 2025 – large-scale pilot
- September 2026 – all businesses must be able to accept e-invoices. B2B e-invoicing and e-reporting for large- and medium-sized companies (more than 250 employees, and exceeding either of the following: EUR 50 million turnover or EUR 43 million balance sheet) with an option to extend by a further three months to December 2026, and
- September 2027 – e-invoicing and e-reporting for small businesses below the above thresholds – also with an option to extend by a further three months to December 2027.
Germany
The German Bundesrat approves e-invoicing for B2B transactions within Germany, gradually commencing 1 January 2025 and with full implementation in 2028. In particular, on 22 March 2024, the German Bundesrat approved the law mandating B2B e-invoicing starting January 2027 for companies with turnover exceeding EUR 800,000, and in January 2028 for those below this threshold. However, all companies must be capable of receiving structured electronic invoices as of 1 January 2025. On 15 October 2024, the Federal Ministry of Finance issued a document about the principles for the application of the new e-invoicing regulations.
We recommend ensuring that businesses in Germany prepare to comply with mandatory B2B e-invoicing requirements by the designated deadline.
Environment – social – government (ESG) levies
In the EU, we are currently witnessing significant developments in the ESG (environmental, social, governance) tax landscape. New levies are constantly being introduced, both small and large, which require our attention. These include, among others, plastic packaging taxes, sugar taxes and the extended producer responsibility. All of these topics fall within the realm of ESG and are becoming increasingly important.